Anticancer Biosciences is developing a new antimitotic cancer therapeutics using natural products
Chengdu, China (PRUnderground) March 1st, 2021 Anticancer Biosciences is applying its synthetic lethality expertise for better cancer therapies. The identification of novel antimitotic agents that do not lead to severe side effects is much significant in the present day oncology drug development. At the J. Michael Bishop Institute of Cancer Research (MBICR), China’s world-leading cancer research Centre, there are many advanced research initiatives in this context. A recently published study from our Natural Product Drug Discovery Group (NPDD) highlights a novel screening method in uncoveri...
Source: prunderground.com